Baker Bros. Advisors (GP) LLC's Net Worth
$0
Who is Baker Bros. Advisors (GP) LLC?
Baker Bros. Advisors (GP) LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Seagen Inc., RHYTHM PHARMACEUTICALS, INC., BeiGene, Ltd., INCYTE CORP, Invitae Corp, Prelude Therapeutics Inc, XOMA Corp, Kiniksa Pharmaceuticals, Ltd., Mirati Therapeutics, Inc., Zymeworks Inc., Intellia Therapeutics, Inc., Entrada Therapeutics, Inc., IGM Biosciences, Inc., Kodiak Sciences Inc., ACADIA PHARMACEUTICALS INC, BIOCRYST PHARMACEUTICALS INC, IDERA PHARMACEUTICALS, INC., DBV Technologies S.A., TScan Therapeutics, Inc., Neurogene Inc., Atreca, Inc., Aeglea BioTherapeutics, Inc., BELLICUM PHARMACEUTICALS, INC, HOOKIPA Pharma Inc., Talis Biomedical Corp, ALEXION PHARMACEUTICALS INC, MADRIGAL PHARMACEUTICALS, INC., SYNAGEVA BIOPHARMA CORP, GENOMIC HEALTH INC, Principia Biopharma Inc., vTv Therapeutics Inc., Kymera Therapeutics, Inc., BICYCLE THERAPEUTICS PLC, Immunocore Holdings plc, and KALA BIO, Inc..
SEC CIK
Baker Bros. Advisors (GP) LLC's CIK is 0001580575
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $49.25
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +176.03% | 2.05M |
$17.00 | $15,045,000.00 | 3.21M |
Oct 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BeiGene, Ltd. (BGNE) Snapshot price: $191.32
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +34.99% | 65.36K |
—
|
—
| 252.19K |
Jun 5
| |||
Form 4
| -9.43% | -1.10M |
$180.50 | -$198,550,000.00 | 10.57M |
Nov 14
| |||
Form 4
| +38.25% | 51.69K |
—
|
—
| 186.83K |
Jun 15
| |||
Form 4
| +97.65% | 66.77K |
—
|
—
| 135.14K |
Jun 22
| |||
Form 4
| +83.93% | 31.2K |
—
|
—
| 68.37K |
Jun 16
| |||
Form 4
| -1.03% | -121.15K |
$220.50 | -$26,714,457.00 | 11.67M |
Jan 4
| |||
Form 4
| -11.53% | -1.54M |
$220.50 | -$333,295,893.00 | 11.81M |
Oct 13 - Dec 4
| |||
Form 4
| +276.32% | 14.58M |
$14.23 | $207,544,548.74 | 19.86M |
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| -35.69% | -651.49K |
—
|
—
| 1.17M |
Jun 5 - Jun 6
| |||
Form 4
| +15,636.87% | 5.81M |
$108.00 | $627,922,800.00 | 5.85M |
Aug 2
| |||
Form 4
| +0.05% | 37.16K |
—
|
—
| 79.73M |
Jun 6
| |||
Form 4
| +51.44% | 1.98M |
$101.00 | $199,999,998.00 | 5.83M |
Jan 18
| |||
Form 4
| -71.13% | -35.00K |
—
|
—
| 14.2K |
Oct 13
| |||
Form 4
| +4.79% | 176.06K |
$71.00 | $12,499,976.00 | 3.85M |
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 19
| |||
Form 4
| +92.04% | 1.76M |
$32.00 | $56,335,840.00 | 3.67M |
Nov 18
| |||
Form 4
| +64.92% | 82.25M |
$10.01 | $47,654,320.28 | 208.94M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Invitae Corp (NVTA) Snapshot price: $0.019
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +15.40% | 1.11M |
$4.50 | $4,999,999.50 | 8.33M |
Mar 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
| +11.31% | 733.33K |
$6.00 | $4,399,998.00 | 7.21M |
Nov 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prelude Therapeutics Inc (PRLD) Snapshot price: $5.18
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| +0.10% | 10.38K |
$12.85 | $133,331.60 | 10.13M |
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
| +49.15% | 9.91M |
$19.00 | $29,999,993.00 | 30.08M |
Mar 27 - Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kiniksa Pharmaceuticals, Ltd. (KNSA) Snapshot price: $24.93
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.45% | 12.69K |
—
|
—
| 2.85M |
Jun 5
| |||
Form 4
| +0.62% | 17.49K |
—
|
—
| 2.84M |
Jun 6
| |||
Form 4
| +0.71% | 20K |
—
|
—
| 2.82M |
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| -57.03% | -170.74K |
—
|
—
| 128.66K |
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
∞
| 3M |
$18.00 | $54,000,000.00 | 3M |
Feb 9 - May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||